We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LLTC
251
DELISTED
Linear Technology Corp
LLTC
| $38.1M | 0.05% |
611,260
+1,032
| +0.2% | +$62.9K |
|
252
FerroAtlántica
GSM
$628M
| $37.7M | 0.05% |
3,477,017
+287,730
| +9% | +$2.97M |
|
|
SYKE
253
DELISTED
SYKES Enterprises Inc
SYKE
| $37M | 0.05% |
1,282,633
+7,193
| +0.6% | +$201K |
|
254
The Mosaic Company
MOS
$7.09B
| $36.9M | 0.05% |
1,258,829
-1,510,458
| -55% | -$40.5M |
|
255
Steven Madden
SHOO
$3.12B
| $36.2M | 0.05% |
1,518,810
-984
| -0.1% | -$23.9K |
|
256
NVR
NVR
$17.2B
| $33.6M | 0.04% |
+20,149
| New | +$32.2M |
|
|
OPLN
257
Openlane
OPLN
$4.17B
| $33.4M | 0.04% |
2,068,435
-216,567
| -9% | -$3.46M |
|
|
FINL
258
DELISTED
Finish Line
FINL
| $33.3M | 0.04% |
1,770,108
+3,882
| +0.2% | +$84.5K |
|
|
NCI
259
DELISTED
Navigant Consulting, Inc.
NCI
| $32.9M | 0.04% |
1,255,504
-932,508
| -43% | -$22.1M |
|
|
NLSN
260
DELISTED
Nielsen Holdings plc
NLSN
| $32.9M | 0.04% |
783,440
+327
| +0% | +$15K |
|
261
ABM Industries
ABM
$2.8B
| $32.7M | 0.04% |
800,477
+3,717
| +0.5% | +$151K |
|
262
Enterprise Products Partners
EPD
$83.8B
| $32.6M | 0.04% |
+1,204,758
| New | +$31.4M |
|
263
Integra LifeSciences
IART
$1.54B
| $32.5M | 0.04% |
756,570
-66,152
| -8% | -$2.69M |
|
|
264
Verizon
VZ
$194B
| $32.3M | 0.04% |
605,915
-8,662,223
| -93% | -$433M |
|
|
PMC
265
DELISTED
PharMerica Corporation
PMC
| $32.3M | 0.04% |
1,283,903
+915,786
| +249% | +$23.1M |
|
266
TD Synnex
SNX
$19.4B
| $31.5M | 0.04% |
521,206
-3,260
| -0.6% | -$185K |
|
|
TPC
267
Tutor Perini Cor
TPC
$4.57B
| $31.4M | 0.04% |
1,119,997
-313,299
| -22% | -$7.59M |
|
268
Hanover Insurance
THG
$7.63B
| $31.2M | 0.04% |
342,647
-2,238
| -0.6% | -$187K |
|
269
Azenta
AZTA
$1.26B
| $31M | 0.04% |
1,818,831
+6,475
| +0.4% | +$97.4K |
|
270
Thor Industries
THO
$3.99B
| $30.8M | 0.04% |
307,804
-552,842
| -64% | -$49.9M |
|
|
NSM
271
DELISTED
Nationstar Mortgage Holdings
NSM
| $30.4M | 0.04% |
1,685,341
-5,920
| -0.4% | -$97.6K |
|
272
Baidu
BIDU
$35.8B
| $30.2M | 0.04% |
183,678
+87
| +0% | +$14.8K |
|
273
First Citizens BancShares
FCNCA
$24.6B
| $30.1M | 0.04% |
84,869
-69
| -0.1% | -$22.5K |
|
|
LPNT
274
DELISTED
LifePoint Health, Inc.
LPNT
| $29.5M | 0.04% |
518,765
+190,816
| +58% | +$11M |
|
|
ACRE
275
Ares Commercial Real Estate
ACRE
$252M
| $29.4M | 0.04% |
2,142,123
-5,943
| -0.3% | -$79K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.